Bank of America Corporation »

Denali Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.8M 459k 21.46
2023-09-30 $6.1M 296k 20.63
2023-06-30 $8.0M 270k 29.51
2023-03-31 $9.7M 420k 23.04
2022-12-31 $9.3M 335k 27.81
2022-06-30 $3.5M 119k 29.43
2021-12-31 $5.8M 129k 44.60
2021-06-30 $5.0M 64k 78.44
2021-03-31 $3.0M 52k 57.12
2020-12-31 $4.0M 47k 83.77
2020-09-30 $1.0M 29k 35.85
2020-06-30 $808k 33k 24.20
2020-03-31 $483k 28k 17.48
2019-12-31 $436k 25k 17.41
2019-09-30 $670k 44k 15.35
2019-03-31 $1.9M 82k 23.22
2018-12-31 $359k 17k 20.68
2018-06-30 $64k 4.2k 15.14
2018-03-31 $30k 1.5k 20.08
2017-12-31 $4.0k 284 14.08